Norwood and Gingrich Butt On Reform Pace

The managed care reform bill sponsored by Republican Rep. Charles Norwood of Georgia is gaining momentum — at least, within the halls of Congress. Norwood allies have polled, informally, rank-and-file House Republicans and found growing support for his Patient Access to Responsible Care Act, or PARCA. Tangible evidence: The bill has more than 200 co-sponsors.

But in a speech to the American Association of Health Plans, House Speaker Newt Gingrich said that Congress should deal with the larger issue of the direction of health care before it takes up specific HMO issues. Gingrich wants time for the GOP task force on health care quality, which he set up, to come up with its own recommendations for a health care consumer bill of rights.

Undaunted, Norwood vows to press ahead, regardless of Gingrich and in spite of employer concerns and HMO resentment about what's viewed as the real bone of contention: provisions permitting patients to sue health plans if denied care. The Health Benefits Coalition issued a report saying it would cost insurance companies $1 billion each year in jury verdicts and lawyers' fees, based on physicians' experiences with malpractice suits.

Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to or online at

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.